Seres Therapeutics Inc (MCRB)

02:06 AM

CCORF Maintains Seres Therapeutics(MCRB.US) With Buy Rating, Maintains Target Price $22 - Moomoo

02:06 AM

May 05, 2026

MSN Money - MSN

May 05, 2026

May 05, 2026

Seres Therapeutics 1Q 2026: Revenue $358K, EPS $(2.08) — 10-Q Summary - TradingView

May 05, 2026

May 05, 2026

Seres Therapeutics (NASDAQ: MCRB) Q1 2026 loss and going-concern risk - Stock Titan

May 05, 2026

May 05, 2026

Seres Therapeutics: Q1 Earnings Snapshot - marketscreener.com

May 05, 2026

May 05, 2026

Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - The Manila Times

May 05, 2026

May 05, 2026

Seres Therapeutics (Nasdaq: MCRB) Q1 2026 results and cash runway - Stock Titan

May 05, 2026

May 05, 2026

Seres awaits SER-155 data in weeks with cash through Q3 - Stock Titan

May 05, 2026

May 04, 2026

Seres presents preclinical data on IBD drug candidate SER-603 - Investing.com UK

May 04, 2026

May 04, 2026

Seres presents preclinical data on IBD drug candidate SER-603 By Investing.com - Investing.com South Africa

May 04, 2026

May 04, 2026

Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease - The Manila Times

May 04, 2026

May 04, 2026

Experimental IBD microbiome therapy earns DDW poster honor - Stock Titan

May 04, 2026

May 04, 2026

Seres Therapeutics Presents Preclinical Data at Digestive - GlobeNewswire

May 04, 2026

Apr 30, 2026

MCRB stock declines as Seres Therapeutics pauses SER-155 phase 2 study and shrinks headcount by 30% - MSN

Apr 30, 2026

Apr 29, 2026

Seres Therapeutics (MCRB) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Apr 29, 2026

Apr 27, 2026

Equity plan and director votes in Seres Therapeutics (NASDAQ: MCRB) 2026 proxy - Stock Titan

Apr 27, 2026

Apr 27, 2026

Microbiome Therapeutics Market is Going to Booming Growth - openPR.com

Apr 27, 2026

Apr 26, 2026

Chardan Capital Downgrades Seres Therapeutics (MCRB) - MSN

Apr 26, 2026

Apr 24, 2026

MCRB Price Today: Seres Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 24, 2026

Apr 22, 2026

Seres Therapeutics (NASDAQ:MCRB) Shares Pass Below 200 Day Moving AverageHere's What Happened - MarketBeat

Apr 22, 2026

Apr 20, 2026

Seres Therapeutics (MCRB) Presents Key Data at ESCMID Congress - GuruFocus

Apr 20, 2026

Apr 20, 2026

Seres Therapeutics (MCRB) Showcases Research at ESCMID 2026 Cong - GuruFocus

Apr 20, 2026

Apr 20, 2026

Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026 - The Manila Times

Apr 20, 2026

Apr 20, 2026

Seres spotlights microbiome data for transplant patients at ESCMID - Stock Titan

Apr 20, 2026

Apr 11, 2026

Aug Catalysts: Is Seres Therapeutics Inc impacted by rising rates2026 AllTime Highs & Safe Entry Trade Signal Reports - baoquankhu1.vn

Apr 11, 2026

Apr 11, 2026

Seres Therapeutics Stock Price Drops Below 50-Day Average - National Today

Apr 11, 2026

Apr 11, 2026

Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Below Fifty Day Moving AverageHere's What Happened - MarketBeat

Apr 11, 2026

Apr 10, 2026

Will Seres Therapeutics Inc benefit from green energy policies2026 Chart Watch & High Accuracy Trade Alerts - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Is Seres Therapeutics (MCRB) Stock a Buy Now | Price at $8.51, Down 2.34%Volume Leaders - Newser

Apr 10, 2026

Apr 09, 2026

Seres Therapeutics to Present at CARB-X Investor Day - Bitget

Apr 09, 2026

Apr 09, 2026

Seres brings CARB-X-backed ICU infection therapy to Munich event - Stock Titan

Apr 09, 2026

Apr 08, 2026

Aug Ideas: Should I invest in Seres Therapeutics Inc before earnings2026 Setups & Low Drawdown Trading Strategies - baoquankhu1.vn

Apr 08, 2026

Apr 06, 2026

VIX Spike: Does Seres Therapeutics Inc have declining or rising EPSWeekly Stock Analysis & Daily Entry Point Alerts - baoquankhu1.vn

Apr 06, 2026

Apr 02, 2026

MCRB SEC FilingsSeres Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 02, 2026

Apr 02, 2026

What are the biggest risks for Seres Therapeutics (MCRB) Stock | Price at $9.27, Up 4.63%Capital Preservation - Cổng thông tin điện tử tỉnh Lào Cai

Apr 02, 2026

Mar 31, 2026

Market Fear: Can Seres Therapeutics Inc weather a recessionDip Buying & Free High Return Stock Watch Alerts - baoquankhu1.vn

Mar 31, 2026

Mar 29, 2026

Market Rankings: Is Seres Therapeutics Inc in a bullish channelTrade Volume Summary & Safe Capital Growth Stock Tips - baoquankhu1.vn

Mar 29, 2026

Mar 26, 2026

Layoff Tracker: Takeda Restructuring Will Affect Workforce, Could Include Layoffs - BioSpace

Mar 26, 2026

Mar 25, 2026

Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Below 50 Day Moving AverageHere's Why - MarketBeat

Mar 25, 2026

Mar 24, 2026

Seres Therapeutics cuts 25% of workforce to extend cash runway into Q2 2026 - MSN

Mar 24, 2026

Mar 23, 2026

Seres Therapeutics (MCRB) price target increased by 31.25% to 21.42 - msn.com

Mar 23, 2026

Mar 22, 2026

If You Invested $1,000 in Seres Therapeutics Inc (MCRB) - Stock Titan

Mar 22, 2026